Search
for
Sort by
Research 91–120 of 119
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Back to the Future: From Appendage Development Toward Future Human Hair Follicle Neogenesis
- Metformin and Malignant Tumors: Not Over the Hill
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Combinatorial expression of cell cycle regulators is more suitable for immortalization than oncogenic methods in dermal papilla cells
- Amphiregulin in Fibrotic Diseases and Cancer
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Molecular landscape of lung cancer: insights into therapeutic targets and clinical outcomes
- Amphiregulin in Fibrotic Diseases and Cancer
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Medical Dermatology
- Optical Coherence Tomography Angiography Findings in Polycystic Ovary Syndrome
- Imatinib-induced classical lichen planopilaris in blaschko-linear distribution leading to cicatricial alopecia
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- The Chemotherapy Use and Adverse Effects of Patients with Lung Cancer at Regional General Hospital in Surabaya, Indonesia
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Unusual Presentation of Childhood Leukemia With Vaginal Bleeding: A Case Report
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- Drug Repurposing against KRAS Mutant G12C: A Machine Learning, Molecular Docking, and Molecular Dynamics Study
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.